Correlation Between Memphis Pharmaceuticals and Ismailia National

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Ismailia National at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Ismailia National into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and Ismailia National Food, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Ismailia National and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Ismailia National. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Ismailia National.

Diversification Opportunities for Memphis Pharmaceuticals and Ismailia National

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Memphis and Ismailia is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Ismailia National Food in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ismailia National Food and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Ismailia National. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ismailia National Food has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Ismailia National go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Ismailia National

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 4.58 times more return on investment than Ismailia National. However, Memphis Pharmaceuticals is 4.58 times more volatile than Ismailia National Food. It trades about 0.12 of its potential returns per unit of risk. Ismailia National Food is currently generating about -0.01 per unit of risk. If you would invest  3,705  in Memphis Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of  1,443  from holding Memphis Pharmaceuticals or generate 38.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  Ismailia National Food

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Ismailia National Food 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ismailia National Food has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Ismailia National is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Memphis Pharmaceuticals and Ismailia National Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and Ismailia National

The main advantage of trading using opposite Memphis Pharmaceuticals and Ismailia National positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Ismailia National can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ismailia National will offset losses from the drop in Ismailia National's long position.
The idea behind Memphis Pharmaceuticals and Ismailia National Food pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.